机译:具有仿生表面的亚50纳米纳米颗粒可顺序克服粘膜扩散屏障和上皮吸收屏障
Sichuan Univ, West China Sch Pharm, Minist Educ, Key Lab Drug Targeting & Drug Delivery Syst, Chengdu 610041, Peoples R China|Natl Shanghai Ctr New Drug Safety Evaluat & Res, Shanghai 201203, Peoples R China;
Sun Yat Sen Univ, Dept Biomed Engn, Guangzhou 510006, Guangdong, Peoples R China;
Sichuan Univ, West China Sch Pharm, Minist Educ, Key Lab Drug Targeting & Drug Delivery Syst, Chengdu 610041, Peoples R China;
Sichuan Univ, West China Sch Pharm, Minist Educ, Key Lab Drug Targeting & Drug Delivery Syst, Chengdu 610041, Peoples R China;
Sichuan Univ, West China Sch Pharm, Minist Educ, Key Lab Drug Targeting & Drug Delivery Syst, Chengdu 610041, Peoples R China;
Sichuan Univ, West China Sch Pharm, Minist Educ, Key Lab Drug Targeting & Drug Delivery Syst, Chengdu 610041, Peoples R China;
机译:仿生病毒和充电可逆纳米颗粒以依次克服粘液和口腔胰岛素递送的上皮屏障
机译:硫醇化纳米颗粒克服了胰岛素口服递送的粘液屏障和上皮屏障
机译:通过使用表面聚环氧乙烷(PEO)克服肠道粘液(PEO)的肠道粘液和上皮屏障,增强了Cabazitaxel的口腔吸收和抗癌疗效(PEO)饰有带正电荷的聚合物 - 脂质杂交纳米颗粒
机译:比较三种不同的上皮细胞培养模型以研究跨生物屏障的药物吸收
机译:打破粘膜屏障:SIV感染过程中调查MicroRNA在肠上皮屏障破坏中的作用
机译:雷洛昔芬/SBE-β-CD包合物与壳聚糖配制成纳米颗粒克服了吸收障碍提高了生物利用度
机译:雷洛昔芬/ SBE-β-CD包合物配制成含壳聚糖的纳米颗粒,以克服生物利用度增强的吸收屏障